XML 19 R8.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Capital Stock
6 Months Ended
Jun. 30, 2011
Capital Stock

3. CAPITAL STOCK

 

The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model, with the following weighted average assumptions for options granted in the three and six months ended June 30, 2010 and 2011.

 

 

Three Months Ended

June 30,

 

Six Months Ended

June 30,

  2010   2011   2010   2011
                       
Risk-free interest rate   1.45%   1.00%   1.44%   1.00%
Expected lives   2.8 years   2.9 years   2.9 years   2.9 years
Expected volatility   68%   82%   68%   82%
Expected dividend yield   0%   0%   0%   0%
                           

 

 
 

A summary of the Company's stock option plans, excluding options to purchase fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split is as follows:

 

 

Year Ended

December 31, 2010

Six Months Ended

June 30, 2011

 

 

 

 

 

Options

 

Weighted

Average

Exercise

Price

 

 

 

 

 

Options

 

Weighted

Average

Exercise

Price

Outstanding at beginning of period   1,291,634   $ 11.846     1,341,876   $ 11.003  
  Granted at market   104,900   $ 5.945     74,750   $ 6.839  
  Cancelled   (53,459 ) $ 21.572     (67,861 ) $ 12.873  
  Exercised   (1,199 ) $ 5.834     (3,330 ) $ 4.748  
Outstanding at end of period   1,341,876   $ 11.003     1,345,435   $ 10.693  
Exercisable at end of period   1,142,209   $ 11.871     1,137,906   $ 11.567  

 

The estimated fair value of stock options granted during the six months ended June 30, 2011 and 2010 was computed to be approximately $269 and $112 thousand, respectively. The amount is amortized ratably over the vesting period of the options. The per share weighted average estimated fair value of options granted during the six months ended June 30, 2011 and 2010 was computed to be approximately $3.60 and $3.76, respectively. The total intrinsic value of options exercised during the six months ended June 30, 2011 and 2010 was approximately $2 thousand and $1 thousand, respectively. The cash proceeds from options exercised during the six months ended June 30, 2011 and 2010 were approximately $16 thousand and $5 thousand, respectively.

 

The following table summarizes information about stock options outstanding and exercisable at June 30, 2011, excluding outstanding options to purchase an aggregate of 124.3 fractional shares resulting from the Company's December 2010 1-for-10 reverse stock split with a weighted average remaining contractual life of 3.17 years, a weighted average exercise price of $13.15 and exercise prices ranging from $3.40 to $31.50. The Company intends to issue whole shares only from option exercises.

 

  Options Outstanding Options Exercisable  
Exercise Prices Number of
Options
Outstanding
at
June 30,
2011
Weighted
Average
Remaining
Contractual
Life in Years
Weighted
Average
Exercise
Price
Number of
Options
Exercisable
at
June 30,
2011
Weighted
Average
Exercise
Price
 
$2.70 - $4.96   304,907     7.44   $ 4.473     162,665   $ 4.288  
$4.97 - $8.70   249,472     5.03   $ 7.193     194,567   $ 7.286  
$8.71 - $12.00   269,957     2.78   $ 9.567     269,332   $ 9.568  
$12.01 - $15.90   270,118     3.58   $ 13.548     269,493   $ 13.547  
$15.91 - $31.50   250,981     4.52   $ 19.866     241,849   $ 19.925  
$2.70 - $31.50   1,345,435     4.74   $ 10.693     1,137,906   $ 11.567  
                                     

 

As of June 30, 2011, there was approximately $618 thousand of total unrecognized compensation expense related to outstanding stock options. That expense is expected to be recognized over a weighted average period of 1.7 years, with approximately $206 thousand to be recognized in the six months ending December 31, 2011 and all the cost to be recognized as of May 2015, assuming all options vest according to the vesting schedules in place at June 30, 2011. As of June 30, 2011, the aggregate intrinsic value of outstanding options was approximately $2.4 million and the aggregate intrinsic value of exercisable options was approximately $1.5 million